Spironolactone metabolism and gynaecomastia.
Overdiek
J W
JW
Merkus
F W
FW
D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D007700:Kinetics; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism*
D013148:Spironolactone; C033554:7 alpha-thiospironolactone